BIOMAT Database Logo BIOMAT Database Logo

Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. 2011

Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, CA 94608, USA.

Alcohol use disorders (AUDs) impact millions of individuals and there remain few effective treatment strategies. Despite evidence that neuronal nicotinic acetylcholine receptors (nAChRs) have a role in AUDs, it has not been established which subtypes of the nAChR are involved. Recent human genetic association studies have implicated the gene cluster CHRNA3-CHRNA5-CHRNB4 encoding the α3, α5, and β4 subunits of the nAChR in susceptibility to develop nicotine and alcohol dependence; however, their role in ethanol-mediated behaviors is unknown due to the lack of suitable and selective research tools. To determine the role of the α3, and β4 subunits of the nAChR in ethanol self-administration, we developed and characterized high-affinity partial agonists at α3β4 nAChRs, CP-601932, and PF-4575180. Both CP-601932 and PF-4575180 selectively decrease ethanol but not sucrose consumption and operant self-administration following long-term exposure. We show that the functional potencies of CP-601932 and PF-4575180 at α3β4 nAChRs correlate with their unbound rat brain concentrations, suggesting that the effects on ethanol self-administration are mediated via interaction with α3β4 nAChRs. Also varenicline, an approved smoking cessation aid previously shown to decrease ethanol consumption and seeking in rats and mice, reduces ethanol intake at unbound brain concentrations that allow functional interactions with α3β4 nAChRs. Furthermore, the selective α4β2(*) nAChR antagonist, DHβE, did not reduce ethanol intake. Together, these data provide further support for the human genetic association studies, implicating CHRNA3 and CHRNB4 genes in ethanol-mediated behaviors. CP-601932 has been shown to be safe in humans and may represent a potential novel treatment for AUDs.

UI MeSH Term Description Entries
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D002755 Choice Behavior The act of making a selection among two or more alternatives, usually after a period of deliberation. Approach Behavior,Approach Behaviors,Behavior, Approach,Behavior, Choice,Behaviors, Approach,Behaviors, Choice,Choice Behaviors
D003216 Conditioning, Operant Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. Instrumental Learning,Learning, Instrumental,Operant Conditioning,Conditionings, Operant,Instrumental Learnings,Learnings, Instrumental,Operant Conditionings
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration

Related Publications

Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
July 2007, Proceedings of the National Academy of Sciences of the United States of America,
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Synthesis of α3β4 Nicotinic Acetylcholine Receptor Modulators Derived from Aristoquinoline That Reduce Reinstatement of Cocaine-Seeking Behavior.
December 2023, Journal of medicinal chemistry,
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
[Novel analgesics: neuronal nicotinic acetylcholine receptor agonists].
October 2001, Sheng li ke xue jin zhan [Progress in physiology],
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
The α3β4 nicotinic acetylcholine receptor antagonist 18-Methoxycoronaridine decreases binge-like ethanol consumption in adult C57BL/6J mice.
September 2019, Alcohol (Fayetteville, N.Y.),
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.
October 2009, The EMBO journal,
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
February 2007, Biochemical pharmacology,
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake.
January 2016, PloS one,
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Ethanol interaction with α3β4 nicotinic acetylcholine receptors in neurons of the laterodorsal tegmentum.
December 2021, Alcoholism, clinical and experimental research,
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Dopamine partial receptor agonists reduce ethanol intake in the rat.
February 1996, European journal of pharmacology,
Susmita Chatterjee, and Pia Steensland, and Jeffrey A Simms, and Joan Holgate, and Jotham W Coe, and Raymond S Hurst, and Christopher L Shaffer, and John Lowe, and Hans Rollema, and Selena E Bartlett
Potent modulation of neuronal nicotinic acetylcholine receptor-channel by ethanol.
October 1996, Neuroscience letters,
Copied contents to your clipboard!